United States · Who invested in Claris Biotherapeutics?
Claris Biotherapeutics's investors include RA Capital Management, Novo Holdings, Janus Henderson Investors, Catalio Capital Management and Samsara BioCapital.
2026
$5.6MDebt$118MSeries B
United States · Series B startup
Who invested in Claris Biotherapeutics
Funding summaryUpdated 26 Oct 2026
$124Mraised across 2 rounds since 2025, from 2 sources
$5.6MDebt$118MSeries B
- Latest round
- Series B, $118MJul 2026
- Step-upi
- 21.1×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Debt, $5.6M Mar 2025
- Biggest round
- $118M Series B · Jul 2026
- Between rounds
- 16 months from the last two
The rounds
- Jul 2026Series B$118M2 new3 returning
RA Capital Management
Novo Holdings
Janus Henderson Investors
Catalio Capital Management
Samsara BioCapital
Source recordedSEC filing: $56M sold, first sale Aug 2026
- Mar 2025Debt$5.6M3 new
Source recordedSEC filing: $3.3M sold, first sale Feb 2025
Founders and team
From Claris Biotherapeutics's own website: 3 on the team.
- Stephen BradyPresident and Chief Executive Officer
- Brian BaumChief Commercial Officer
- Henry RathChief Business Officer
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Claris Biotherapeutics
How much has Claris Biotherapeutics raised?
Claris Biotherapeutics has raised $124M across 2 rounds since 2025.
When did Claris Biotherapeutics last raise?
Claris Biotherapeutics's most recent round was a Series B of $118M in Jul 2026.
What was Claris Biotherapeutics's biggest round?
Its most recent round, $118M in Jul 2026, is also its largest on record.
Who backed Claris Biotherapeutics first?
Claris Biotherapeutics's first round on record, in Mar 2025, was backed by RA Capital Management, Novo Holdings and Janus Henderson Investors.
What stage is Claris Biotherapeutics at?
Claris Biotherapeutics's latest named round is a Series B, in Jul 2026.
Where is Claris Biotherapeutics based?
Claris Biotherapeutics is based in the United States.
Companies like Claris Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.